Paris - Delayed Quote • EUR
Ipsen S.A. (IPN.PA)
As of 3:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
865,900.00
865,900.00
971,400.00
893,300.00
771,300.00
Investing Cash Flow
-1,072,200.00
-1,072,200.00
-458,600.00
-332,000.00
-163,700.00
Financing Cash Flow
-458,400.00
-458,400.00
-164,200.00
-421,800.00
-307,500.00
Other Cash Adjustment Inside Change in Cash
13,600.00
13,600.00
1,900.00
24,100.00
--
End Cash Position
519,500.00
519,500.00
1,165,500.00
809,100.00
639,600.00
Capital Expenditure
-182,900.00
-182,900.00
-252,900.00
-417,900.00
-140,700.00
Issuance of Debt
2,622,900.00
2,622,900.00
1,228,800.00
686,400.00
11,800.00
Repayment of Debt
-2,913,700.00
-2,913,700.00
-1,263,300.00
-966,000.00
-900.00
Repurchase of Capital Stock
-39,500.00
-39,500.00
-11,300.00
-36,700.00
-36,400.00
Free Cash Flow
683,000.00
683,000.00
718,500.00
475,400.00
630,600.00
12/31/2020 - 12/7/2005
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
2186.HK Luye Pharma Group Ltd.
2.610
-0.38%
3692.HK Hansoh Pharmaceutical Group Company Limited
15.380
-1.79%
EAPI.PA Euroapi S.A.
2.6140
+1.00%
SUPN Supernus Pharmaceuticals, Inc.
29.09
+0.74%
MRK.DE Merck KGaA
145.70
-0.72%
PCRX Pacira BioSciences, Inc.
26.16
+0.21%
EVO Evotec SE
7.04
-1.54%
COLL Collegium Pharmaceutical, Inc.
35.01
+0.69%
DVAX Dynavax Technologies Corporation
11.46
+1.01%
ALKS Alkermes plc
23.65
-0.46%